Literature DB >> 17574455

Simvastatin attenuates the activity of matrix metalloprotease-9 in aneurysmal aortic tissue.

J Evans1, J T Powell, E Schwalbe, I M Loftus, M M Thompson.   

Abstract

To investigate whether statins reduce the concentration of MMP-9 in the aortic wall, we randomised patients undergoing elective open repair of an abdominal aortic aneurysm (AAA) to a pre-operative course of either simvastatin or placebo. MMPs in aortic biopsies were measured using gelatin zymography. Although recruitment closed early because of increasing statin use among eligible patients, with only 21 patients we demonstrated a 40% reduction in MMP-9 levels in the AAA wall in patients randomised to simvastatin. This provides a possible molecular mechanism to explain the reportedly beneficial effects of statins to slow AAA growth.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17574455     DOI: 10.1016/j.ejvs.2007.04.011

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  18 in total

1.  The role of atorvastatin in regulating the immune response leading to vascular damage in a model of Kawasaki disease.

Authors:  S Blankier; B W McCrindle; S Ito; R S M Yeung
Journal:  Clin Exp Immunol       Date:  2011-03-01       Impact factor: 4.330

2.  Role of matrix metalloproteinase-9 in the development of diabetic retinopathy and its regulation by H-Ras.

Authors:  Renu A Kowluru
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-03-10       Impact factor: 4.799

3.  Association of statin prescription with small abdominal aortic aneurysm progression.

Authors:  Craig D Ferguson; Paula Clancy; Bernard Bourke; Philip J Walker; Anthony Dear; Tim Buckenham; Paul Norman; Jonathan Golledge
Journal:  Am Heart J       Date:  2010-02       Impact factor: 4.749

Review 4.  Diagnostic and therapeutic strategies for small abdominal aortic aneurysms.

Authors:  Ahmed Klink; Fabien Hyafil; James Rudd; Peter Faries; Valentin Fuster; Ziad Mallat; Olivier Meilhac; Willem J M Mulder; Jean-Baptiste Michel; Francesco Ramirez; Gert Storm; Robert Thompson; Irene C Turnbull; Jesus Egido; Jose L Martín-Ventura; Carlos Zaragoza; Didier Letourneur; Zahi A Fayad
Journal:  Nat Rev Cardiol       Date:  2011-02-08       Impact factor: 32.419

5.  Statin therapy reduces growth of abdominal aortic aneurysms.

Authors:  Wassef Karrowni; Saadeddine Dughman; Georges P Hajj; Francis J Miller
Journal:  J Investig Med       Date:  2011-12       Impact factor: 2.895

Review 6.  Cysteine protease cathepsins and matrix metalloproteinases in the development of abdominal aortic aneurysms.

Authors:  Yanwen Qin; Xu Cao; Yaoguo Yang; Guo-Ping Shi
Journal:  Future Cardiol       Date:  2013-01

Review 7.  Medical management of small abdominal aortic aneurysms.

Authors:  B Timothy Baxter; Michael C Terrin; Ronald L Dalman
Journal:  Circulation       Date:  2008-04-08       Impact factor: 29.690

Review 8.  Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery.

Authors:  Robert D Sanders; Amanda Nicholson; Sharon R Lewis; Andrew F Smith; Phil Alderson
Journal:  Cochrane Database Syst Rev       Date:  2013-07-03

9.  Effect of statin therapy on serum activity of proteinases and cytokines in patients with abdominal aortic aneurysm.

Authors:  Bernd Muehling; Alexander Oberhuber; Hubert Schelzig; Gisela Bischoff; Nikolaus Marx; Ludger Sunder-Plassmann; Karl H Orend
Journal:  Vasc Health Risk Manag       Date:  2008

Review 10.  Pathogenic mechanisms and the potential of drug therapies for aortic aneurysm.

Authors:  Bo Liu; David J Granville; Jonathan Golledge; Zamaneh Kassiri
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-02-21       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.